3:30 pm - 3:35 pm
Chair: Landon Edgar
3:35 pm - 4:10 pm
Keynote Speaker: Dr. Jennifer Munkley
Harnessing the power of glycans to revolutionise the diagnosis and treatment of prostate cancer.
Click here to read abstract
4:10 pm - 4:35 pm
Invited Speaker: Dr. Heinz Läubli
Enhancing Cancer Immunotherapy by Targeting Cancer-Associated Glycans
Click here to read abstract
4:35 pm - 5:00 pm
Invited Speaker: Dr. Kelly McNagny
PODXL as a broad-spectrum therapeutic target for poor outcome tumors
Click here to read abstract
5:00 pm - 5:15 pm
Oral Abstract: Mathieu Decloquement
Deciphering Siglec ligands in cancer to improve immunotherapy
Click here to read abstract
5:15 pm - 5:30 pm
Oral Abstract: Rita Nehmé
Development of Galectin-7 and Galectin-1-Specific Inhibitors: Immunotherapy and Molecular Imaging in Triple-Negative Breast Cancer
Click here to read abstract
Dr. Heinz Läubli, University of Basel
Dr. Kelly McNagny, University of British Columbia


